Skip to content

Clinical trials

Phase 1 Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 1 Country / region: Taiwan Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20113
20122
20133
20147
20152
20164
20175
201811
20196
20207
20213
20226
20232
20246
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Active, not recruiting16
Terminated13
Recruiting5
Unknown status3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie14
Boehringer Ingelheim6
Novartis Pharmaceuticals4
Amgen3
Astellas Pharma Global Development, Inc.3
AstraZeneca3
AbGenomics B.V Taiwan Branch2
Bayer2
Blueprint Medicines Corporation2
Daiichi Sankyo2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms71
Carcinoma, Non-Small-Cell Lung22
Colorectal Neoplasms10
Neoplasm Metastasis9
Stomach Neoplasms9
Ovarian Neoplasms8
Breast Neoplasms7
Pancreatic Neoplasms7
Triple Negative Breast Neoplasms7
Adenocarcinoma6

Trials

Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.